Biotech startup Vaccitech confidentially files for US IPO
April 8, 2021
Vaccitech, the biotech startup behind the technology used to develop the Oxford-AstraZeneca COVID-19 vaccine, has confidentially filed for a US IPO, the Financial Times reported. The UK-based company could price its offering as early as this month. Vaccitech raised $168 million in a round led by M&G Investment Management in March. The UK Treasury is also said to own a stake in the startup.